191 related articles for article (PubMed ID: 27322463)
1. Human Trial of a Genetically Modified Herpes Simplex Virus for Rapid Detection of Positive Peritoneal Cytology in the Staging of Pancreatic Cancer.
Kelly KJ; Wong J; Gönen M; Allen P; Brennan M; Coit D; Fong Y
EBioMedicine; 2016 May; 7():94-9. PubMed ID: 27322463
[TBL] [Abstract][Full Text] [Related]
2. Oncolytic herpes simplex virus-1 mutant expressing green fluorescent protein can detect and treat peritoneal cancer.
Stanziale SF; Stiles BM; Bhargava A; Kerns SA; Kalakonda N; Fong Y
Hum Gene Ther; 2004 Jun; 15(6):609-18. PubMed ID: 15212719
[TBL] [Abstract][Full Text] [Related]
3. The influence of positive peritoneal cytology on survival in patients with pancreatic adenocarcinoma.
Ferrone CR; Haas B; Tang L; Coit DG; Fong Y; Brennan MF; Allen PJ
J Gastrointest Surg; 2006 Dec; 10(10):1347-53. PubMed ID: 17175453
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of RT-PCR-based detection of peritoneal micrometastases in patients with pancreatic cancer undergoing curative resection.
Kelly KJ; Wong J; Gladdy R; Moore-Dalal K; Woo Y; Gonen M; Brennan M; Allen P; Fong Y; Coit D
Ann Surg Oncol; 2009 Dec; 16(12):3333-9. PubMed ID: 19763694
[TBL] [Abstract][Full Text] [Related]
5. Peritoneal washings cytology combined with immunocytochemical staining in pancreatic cancer.
Nakao A; Oshima K; Takeda S; Kaneko T; Kanazumi N; Inoue S; Nomoto S; Kawase Y; Kasuya H
Hepatogastroenterology; 1999; 46(29):2974-7. PubMed ID: 10576385
[TBL] [Abstract][Full Text] [Related]
6. Peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreas.
Meszoely IM; Lee JS; Watson JC; Meyers M; Wang H; Hoffman JP
Am Surg; 2004 Mar; 70(3):208-13; discussion 213-4. PubMed ID: 15055843
[TBL] [Abstract][Full Text] [Related]
7. Predicting positive peritoneal cytology in pancreatic cancer.
O'Halloran EA; Board T; Lefton M; Devarajan K; Dotan E; Meyer J; Reddy SS
J Cancer Res Clin Oncol; 2021 Jun; 147(6):1825-1832. PubMed ID: 33389074
[TBL] [Abstract][Full Text] [Related]
8. The replication-competent oncolytic herpes simplex mutant virus NV1066 is effective in the treatment of esophageal cancer.
Stiles BM; Bhargava A; Adusumilli PS; Stanziale SF; Kim TH; Rusch VW; Fong Y
Surgery; 2003 Aug; 134(2):357-64. PubMed ID: 12947341
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of cytologic examination of peritoneal washings in pancreatic cancer.
Konishi M; Kinoshita T; Nakagohri T; Inoue K; Oda T; Takahashi S
Arch Surg; 2002 Apr; 137(4):475-80. PubMed ID: 11926958
[TBL] [Abstract][Full Text] [Related]
10. Positive peritoneal lavage cytology is a predictor of worse survival in locally advanced pancreatic cancer.
Clark CJ; Traverso LW
Am J Surg; 2010 May; 199(5):657-62. PubMed ID: 20466112
[TBL] [Abstract][Full Text] [Related]
11. Implications of fine-needle aspiration in patients with resectable pancreatic cancer.
Johnson DE; Pendurthi TK; Balshem AM; Ross E; Litwin S; Eisenberg BL; Hoffman JP
Am Surg; 1997 Aug; 63(8):675-9; discussion 679-80. PubMed ID: 9247432
[TBL] [Abstract][Full Text] [Related]
12. Postoperative cytology for drained fluid from the pancreatic bed after "curative" resection of pancreatic cancers: does it predict both the patient's prognosis and the site of cancer recurrence?
Ishikawa O; Wada H; Ohigashi H; Doki Y; Yokoyama S; Noura S; Yamada T; Sasaki Y; Imaoka S; Kasugai T; Matsunaga T; Takenaka A; Nakaizumi A
Ann Surg; 2003 Jul; 238(1):103-10. PubMed ID: 12832972
[TBL] [Abstract][Full Text] [Related]
13. Virally directed fluorescent imaging improves diagnostic sensitivity in the detection of minimal residual disease after potentially curative cytoreductive surgery.
Adusumilli PS; Eisenberg DP; Chun YS; Ryu KW; Ben-Porat L; Hendershott KJ; Chan MK; Huq R; Riedl CC; Fong Y
J Gastrointest Surg; 2005 Nov; 9(8):1138-46; discussion 1146-7. PubMed ID: 16269385
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic laparoscopy improves staging of pancreatic cancer deemed locally unresectable by computed tomography.
Liu RC; Traverso LW
Surg Endosc; 2005 May; 19(5):638-42. PubMed ID: 15776215
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic cancer. Cytologic study of peritoneal washings.
Lei S; Kini J; Kim K; Howard JM
Arch Surg; 1994 Jun; 129(6):639-42. PubMed ID: 8204039
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous Peritoneal Lavage for the Rapid Staging of Gastric and Pancreatic Cancer.
Pak LM; Coit DG; Eaton AA; Allen PJ; D'Angelica MI; DeMatteo RP; Jarnagin WR; Strong VE; Kingham TP
Ann Surg Oncol; 2017 May; 24(5):1174-1179. PubMed ID: 28058561
[TBL] [Abstract][Full Text] [Related]
17. Clinical implications of peritoneal cytology in potentially resectable pancreatic cancer: positive peritoneal cytology may not confer an adverse prognosis.
Yamada S; Takeda S; Fujii T; Nomoto S; Kanazumi N; Sugimoto H; Kasuya H; Kodera Y; Nagasaka T; Morita S; Nakao A
Ann Surg; 2007 Aug; 246(2):254-8. PubMed ID: 17667504
[TBL] [Abstract][Full Text] [Related]
18. Implications of peritoneal washing cytology in patients with potentially resectable pancreatic cancer.
Yachida S; Fukushima N; Sakamoto M; Matsuno Y; Kosuge T; Hirohashi S
Br J Surg; 2002 May; 89(5):573-8. PubMed ID: 11972546
[TBL] [Abstract][Full Text] [Related]
19. Implications of peritoneal cytology for staging of early pancreatic cancer.
Warshaw AL
Am J Surg; 1991 Jan; 161(1):26-9; discussion 29-30. PubMed ID: 1824810
[TBL] [Abstract][Full Text] [Related]
20. Minimally invasive localization of oncolytic herpes simplex viral therapy of metastatic pleural cancer.
Stiles BM; Adusumilli PS; Bhargava A; Stanziale SF; Kim TH; Chan MK; Huq R; Wong R; Rusch VW; Fong Y
Cancer Gene Ther; 2006 Jan; 13(1):53-64. PubMed ID: 16037824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
